INTRODUCTION 1
Interleukin 1 (IL-1) is involved in many neuroimmune responses such as fever, HPA-axis 2 activation, sickness behavior, and prolonged slow wave sleep (Sheng et al., 1994; Dunn, 2000; 3 Rothwell, 2003; Dube et al., 2005) . In addition, IL-1 signaling contributes to CNS wound healing 4 process (Griffin et al., 1994; Mason et al., 2001) , stress induced learning and memory 5 impairments (Schneider et al., 1998; Rachal Pugh et al., 2001) , and neurodegenerative 6 processes (Shaftel et al., 2008) . Most of these actions are mediated through the type I IL-1 7 receptor (IL-1R1). One explanation for the diverse range of IL-1R1 mediated activities is IL-1R1 8 produces distinct responses in different cell types. For example, in cultured human microglia 9 numerous proinflammatory cytokines, such as IL-1β, IL-6, and TNF-α, are produced following 10 IL-1 stimulation (Lee et al., 1993) . These proinflammatory cytokines can cause exacerbation of 11 neuroinflammation. Conversely, in cultured rat astrocytes, a study showed IL-1 stimulates 12 astrocytes to release nerve growth factor which can mediate neuroprotective effects (Gadient et 13 al., 1990) . In addition, administration of IL-1 in the cerebral ventricle induced cyclooxygenase 2 14 (COX-2) exclusively in endothelial cells comprising brain blood vessels to mediate fever (Cao et 15 al., 2001 ). Therefore, depending on the cell type, IL-1 induces different neuromodulatory 16 molecules and functions. The precise mechanisms of how IL-1 activates specific cell types in 17 vivo remains to be determined. 18
One difficulty in regards to the analysis of IL-1R1 mediated functions is visualization of 19 IL-1R1 expressing cells. In situ hybridization histochemistry (ISHH) has found IL-1R1 mRNA in 20 rat brain endothelial cells (Konsman et al., 2004) and neurons in select brain regions, including 21 basolateral nucleus of the amygdala, arcuate nucleus of the hypothalamus, trigeminal and 22 hypoglossal motor nuclei, and area postrema (Cunningham and De Souza, 1993; Ericsson et al., 23 1995) . However, studies using immunohistochemistry (IHC) to detect IL-1R1 protein have 24 generated discrepant results. IL-1R1 immunoreactivity (IL-1R1-ir) has been found in endothelial 25 1R1 r allele. Mice in which the IL-1R1 r allele was transmitted to the germ line was obtained and 1 confirmed by Southern blot. 2 3
Animals 4
Once a C57BL/6 founder mouse with IL-1R1 r germ line transmission was obtained, it 5 was bred to generate IL-1R1 r/+ and IL-1R1 r/r mice. Cell type specific Tie2Cre-IL-1R1 r/r mice and 6
LysMCre-IL-1R1 r/r mice were generated by crossbreeding Tie2Cre-IL-1R1 +/+ transgenic mice 7 (Jackson Laboratories, Bar Harbor, ME; stock No.004128) or LysMCre-IL-1R1 +/+ mice (Jackson 8
Laboratories, Bar Harbor, ME; stock No.018956) with IL-1R1 r/r mice. In a previous study, Koni et 9 al. had characterized the Tie2Cre transgenic line used in the current study (Koni et al., 2001) . 10
They found the male Tie2Cre transgene carrier deletes loxP flanked sequence in hematopoietic 11 cells and endothelial cells, whereas female Tie2Cre carrier deletes the loxP flanked sequence in 12 the germ line of the offspring, which resulted in a global deletion of the loxP flanked sequence in 13 the next generation without further need of Cre mediated deletion. Therefore to maintain our 14
Tie2Cre-IL-1R1
r/r line, only male Tie2Cre-IL-1R1 r/r mice were used as the Tie2Cre carrier. A 15 female Tie2Cre-IL-1R1 r/r animal was also used to mate with a male IL-1R1 r/r animal to generate 16 an IL-1R1 globally restored heterozygote (IL-1R1 GR/r ) animals. The designation GR indicates 17 that the IL-1R1 restored sequence is in all cell types. Animals with IL-1R1 GR will have the IL-1R1 18 restored without the presence of Cre. IL-1R1 globally restored homozygote (IL-1R1 GR/GR ) 19 animals were obtained by breeding the IL-1R1 GR/r animals with each other. All procedures were 20 approved by The Ohio State University Animal Care and Use Committee. 21 22
Genotyping 23
Genomic DNA was purified from mouse tail tissue using a protocol described previously 24 (An et al., 2014) . Briefly, a 5 mm mouse tail biopsy was incubated in 500 µl lysis buffer for 2 hrs 25 at 56°C with repeated agitation. The lysis buffer contained 10 mM Tris-HCl, pH 8.0, 100 mM 26 EDTA, 0.5% SDS, 0.2 mg/ml ribonuclease A (Invitrogen, Carlsbad, CA), 1 mg/ml proteinase K 1 (Invitrogen, Carlsbad, CA). Samples were centrifuged at 13,000 rpm for 10 min to remove tissue 2 residue. Supernatants were removed and gently mixed with 500 µl isopropanol. Genomic DNA 3 was then pelleted and washed with ice-cold 70% ethanol. DNA pellets were air dried and 4 dissolved in 50 µl of DNAse free water. 5
To detect the knock-in IL-1R1 allele (IL-1R1 r ), the inserted DNA segment target I and 6 target II were separately detected using the following primers: for target 1 (sequence T1, Fig.  7 3A), T1F1 5'-ATAAGAATGCGGCCGCTAAAGTATGTTTTTGAAATAGAAAAGATTG-3' and 8 T1R2 5'-ACCGGAATTCCGCGTTCTTCTTCTTTGGTTTTCGGG-3'; for target 2 (sequence T2, 9 were the same as those used for T1 and T2 respectively). After Cre mediated excision of target 17 1, the restored IL-1R1 allele (IL-1R1 R ) was detected by the following primers: LoxPF1 5'-18 ACAGTCTCTGCAGATAACTTCGTATA-3' and T1R1 (described above). To detect the presence 19 of Cre recombinase, the following primers were used: CreF 5'-CGATGCAACGAGTGATGAGG-20 3' and CreR 5'-CGCATAACCAGTGAAACAGC-3'. 21
Quantitative RT-PCR was performed to compare IL-1R1 globally restored genotype (IL-22
1R1
GR ) with cell type specific IL-1R1 restored genotype. The restored amplicon (primers LoxPF1 23 and T1R1) was amplified using SYBER green quantitative PCR from 1 µg tail genomic DNA 24 
Intracerebroventricular (ICV) injection of IL-1β 4
ICV injections were conducted as described previously (Ching et al., 2007) . Briefly, 8-10 5 week old animals weighing 20-30 g were anesthetized by intraperitoneal injection of 100 mg/kg 6 Nebutal (Abbott Laboratories, North Chicago, IL). Animals were then fastened onto an animal 7 stereotaxic (David Kopf Instruments, Tujunga, CA). A 28 gauge guide cannula was inserted into 8 the right lateral ventricle [anteroposterior (AP), -1 mm; mediolateral (ML), -0.7 mm; dorsoventral 9 (DV), -2.7 mm]. Using a microinjection system, 20 ng of IL-1β (R&D Systems, Minneapolis, MN) 10 dissolved in 10 µl sterile PBS was infused into the ventricle at rate of 0.8 µl/min (KDS Scientific, 11
Holliston, MA). Wounds were closed with surgical staples. After animals recovered from the 12 surgery, they were sacrificed at 4 h, 12 h or 24 h post-surgery. 13 14
Immunohistochemistry 15
For 3HA, Iba-1, GFAP and Ly6C labeling, animals were perfusion fixed with 4% 16 formaldehyde. Brains were removed, post-fixed in 4% formaldehyde for 24 hrs and incubated in 17 20% sucrose at 4 °C for 24 hrs. Brains were then quickly frozen on dry ice and 30-µm thick 18 coronal sections were generated with a cryostat. Sections were directly examined for tdTomato 19 fluorescence by fluorescent microscopy. For double labeling of other cell markers, sections 20 were incubated with 1% sodium borohydride and 0.5% hydrogen peroxide to reduce 21 background. They were incubated with anti-3HA (1:500; rabbit anti-mouse, Cat# 3724; Cell 22
Signaling, Danvers, MA), anti-Iba1 (1:1000; rabbit anti-mouse, Cat# 019-19741; Wako 23 Chemicals, Richmond, VA), anti-GFAP (1:1000; rabbit anti-mouse, Cat# z0334; Dako, 24 Carpinteria, CA) or anti-Ly6C antibody (1:500; rat anti-mouse, Cat# ab54223; Abcam, 25
Cambridge, MA), followed by biotinylated secondary antibody and visualized by Cy2-26 streptavidin (Jackson Immunoresearch, West Grove, PA). For 3HA staining, tyramide signal 1 amplification procedure was performed (PerkinElmer, Waltham, MA) . 2 For COX-2 and CD45 labeling, mice brains were collected at 4 hrs (COX-2) and 12 hrs 3 (CD45) after ICV injections and frozen coronal sections were fixed in acetone/alcohol mixture, 4 followed by incubation in a glucose oxidase and sodium azide solution. After incubation with 5 anti-COX-2 (1:200; rabbit anti-mouse, Cat# 160106; Cayman Chemicals, Ann Arbor, MI) or anti-6 CD45 (1:500; rat anti-mouse, Cat# 550539; BD Pharmingen, Franklin Lakes, NJ) primary 7 antibody and anti-rabbit/anti-rat secondary antibody, labeling was amplified using an ABC 8 solution (Vector Laboratories, Burlingame, CA) and then visualized with a diaminobenzidine 9 (DAB) peroxidase substrate kit (Vector Laboratories, Burlingame, CA Brain endothelial cells were enriched using a modified protocol described by Motoike et 8 al. (Motoike et al., 2000) . In brief, IL-1R1 r/r , IL-1R1 GR/GR or IL-1R1 GR/r animals were first 9 intracardially perfused with PBS. Brains were then dissected and minced into 1 mm fragments 10 with a razor blade. Tissue was then incubated on a shaker plate at 37°C in pre-warmed PBS 11
with Collagenase I (5 mg/ml) and DNase I (120 U/ml) (Worthington, Lakewood, NJ) for 12 approximately 70 min until all the tissue was digested. Cells were pipetted every 10 min during 13 the incubation. At the end of digestion, DMEM containing 10% FBS was added to the cell 14 suspension to neutralize the collagenase activity. Cells were gently pelleted (900 x g, 6 min) and 15 resuspended with 15 ml 25% BSA/PBS. They were then filtered through a 70 µm mesh cell 16 strainer and centrifuged at 2000 x g for 20 min at RT. The dense white myelin layer on the 17 surface was carefully removed by pipetting. Cells were resuspended in PBS containing 0.5 mM 18 EDTA, 60 U/ml DNase I and 3% FBS and kept on ice. All solutions and tissue were kept in dark 19 or covered with a black box during digestion and processing to minimize bleaching of tdTomato 20
fluorescence. 21
For flow cytometric analysis, Fc receptors were blocked with anti-CD16/CD32 antibody 22 (eBioscience, San Diego, CA) for 10 min. Cells were then labeled with fluorescent monocolonal 23 anti-CD31 antibody (eBioscience, San Diego, CA) or isotype control for 45 min at 4°C. Cells 24
were then washed and resuspended in FACS buffer containing 2% FBS in HBSS and 1 μg/ml 25 sodium azide. Cell suspensions were filtered again before cytometric analysis. Approximately 26 1x10 4 events were analyzed using a Becton-Dickinson FACSCaliber (BD Biosciences, San 1 Jose, CA). Data were subsequently analyzed using FlowJo (Treestar; Ashland, OR). 2 3
Bone marrow cell isolation and ex vivo IL-1β challenge 4
Femurs from experimental animals were excised and epiphyses were removed. Bone 5 marrow cells were carefully flushed out using a 23 gauge needle with ice cold HBSS and filtered 6 through a 70 µm nylon cell strainer. Single cell suspensions were then centrifuged and 7 resuspended in 1 ml red blood cell lysing buffer (0.16 M NH 4 Cl, 10 mM KHCO 3 , and 0.13 mM 8 EDTA) for 5 min, followed by the addition of 5 ml of FBS and centrifuged. Cell pellets were 9 resuspended with DMEM containing 10% FBS. Cell concentrations were determined using a 10 Beckman Z2 Coulter Counter (Corixa, Seattle, WA). 11 
RNA isolation and examination of restored IL-1R1 mRNA 1
To examine IL-1R1 mRNA expression in immune cells, spleen and bone marrow cells 2 were isolated for RNA extraction. Spleens were dissected from wild type, IL-1R1 r/r and IL-3
1R1
GR/GR animals. Bone marrow cells from the same genotypes were collected using the 4 protocol in section 2.8. Total RNA was extracted using Trizol reagent (Invitrogen, Carlsbad, CA) 5 according to the manufacturer's protocol. Total RNA concentration and purity was determined 6
by Nanodrop spectrophotometry (Denville, S. Plainfield, NJ) and reversed transcribed to cDNA 7 using a Reverse Transcription Kit (Promega, Madison, WI). To detect the restored IL-1R1 8 mRNA, PCR was performed using the following two pairs of primers: for amplicon EXT1 (an 9 RNA sequence between IL-1R1 Exon IX and Exon X), EXT1F 5'-10 GGGGCTTTATCATCCTCACG-3' and EXT1R 5'-TCTCCCAGGGTCTTGGGATA-3', for 11 amplicon EXT2 (another RNA sequence between IL-1R1 Exon IX and Exon X), EXT2F 5'-12 CCTCACGGCTACAATTGTATGC-3' and EXT2R 5'-CAAACTGTCCCTCCAAGACC-3'. 13 14
Statistical Analysis 15
Data were analyzed by one-way ANOVA, followed by post hoc student t-tests. When 16 appropriate, significant main and interaction effects were subjected to Fisher's PLSD post hoc 17 analyses for further comparison. An alpha level of p≤0.05 was used as the criterion for the 18 rejection of the null hypothesis. All data were analyzed using StatView statistical software (SAS 19 Institute Inc., Cary, NC). Results are reported as treatment means ± standard error of the mean 20 (SEM). 21 22
RESULTS 23
Genomic DNA from putative candidate founders were digested with SacI and labeled by 24 the 3' probe outside the homologous recombination sequence. Blots were stripped and re-25 hybridized with the 5' external probe. Animals with the IL-1R1 r allele showed corresponding 1 fragments consistent with the design. Detailed 3' probe and 5' probe positions are illustrated in 2 Fig. 1 . The correct founder animal (i.e., No. 2 in Fig. 2 ) was used to breed for all subsequent 3
lines. 4
The IL-1R1 r allele was detected also by PCR using two sets of primers (I, T1F1 and 5 T1R2; II, T2F1 and T2R2). IL-1R1 r was indicated by the presence of T1 amplicon (1088 bp) and 6 T2 (440 bp) amplicon (Fig. 3A-C) . Using the same forward primers (T1F1, T2F1) in combination 7 with different reverse primers (T1R1, T2R1), the wild type sequences which correspond to the 8 T1 and T2 locations in the IL-1R1 r allele were PCR amplified. They were designated as T1WT 9 (277 bp) and T2WT (403 bp) respectively (Fig. 3A&B ). Wild type animals were detected by the 10 presence of T1WT and T2WT but the absence of T1 and T2. Conversely, homozygote IL-1R1 r/r 11 animals were detected by the presence of T1 and T2 but not T1WT or T2WT. Heterozygote IL-12
1R1
r/+ animals were determined by the presence of both sets of amplicons. The IL-1R1 r/r mice 13 were crossed with a Tie2Cre or a LysMCre transgenic mouse to generate Tie2Cre-IL-1R1 r/r and 14
LysMCre-IL-1R1
r/r mice. In Tie2Cre-IL-1R1 r/r mice, the Tie2 promoter restricts Cre recombinase 15 expression in endothelial cells and hematopoietic cells during embryogenesis and adulthood 16 (Constien et al., 2001 ) whereas in the LysMCre-IL-1R1 r/r mice Cre recombinase expression is 17 restricted in the myeloid-lineage cells (Narasimha et al., 2010) . Therefore, the interfering 18 segment target 1 was deleted in vascular and hematopoietic cells (Tie2Cre) or peripheral 19 myeloid cells (LysMCre) respectively. In these animals, a restored IL-1R1 allele (IL-1R1 R ) was 20 generated in the corresponding cell type. Cre mediated deletion leaves one loxP sequence in 21 the IL-1R1 intron IX in the restore allele. Consequently, PCR amplification of the restored allele 22 by T1F1 and T1R1 at the T1WT location generates an amplicon (T1WT') with a different size. 23
The IL-1R1 R was also specifically detected by the primers LoxPF1 and T2R1, which would 24 generate an amplicon only from the restored allele (Restored amplicon). The presence of the 25
Cre was detected using primers Cre300F and Cre300R. IL-1R1 globally restored animals (IL-1
1R1
GR/GR ) contained homozygote IL-1R1 R in the absence of Cre. Fig. 3D shows SYBR green 2 quantitative RT-PCR of the Restored amplicon with 1 µg genomic DNA isolated from mouse tail 3 tissue. The cycle number where the amplification curve crossed the threshold detection level 4 reflected the amount of the restored allele in the total DNA. DNA from IL-1R1 GR/GR animals had 5 the earliest amplification, indicating that IL-1R1 R in this animal was most abundant. Amplification 6 of the Restore amplicon from an IL-1R1 GR/r animal was approximately 1 cycle behind an IL-7
GR/GR animal. Thus, the amount of IL-1R1 R in an IL-1R1 GR/r animal was about half of that in 8
GR/GR animal, as expected. More IL-1R1 R was found in the Tie2Cre-IL-1R1 r/r animal 9 than in the LysMCre-IL-1R1 r/r . This was also expected because Tie2Cre should generate IL-10
R in all hematopoietic cells whereas LysMCre should generate IL-1R1 R only in a 11 subpopulation of hematopoietic cells. Because there was no Cre mediated generation of IL-12
R in the IL-1R1 r/r samples, its amplification curve was considered background noise. 13
The IL-1R1 GR/GR animal can be used as an IL-1R1 mRNA reporter animal. Fig. 4 is a 14 collage of confocal images of coronal sections at 0.50 mm anterior to bregma taken from an IL-15
GR/GR animal. The tdTomato fluorescence shows distinct endothelial cell morphology and 16 distribution patterns. Interestingly, the indicated IL-1R1 mRNA was mostly produced by 17 endothelial cells from medium size blood vessels and very rarely from capillaries. They tended 18 to be distributed throughout the brain rather than in a region specific manner. 
GR/GR animals had undetectable tdTomato fluorescence (data not shown). To detect IL-1R1 20 mRNA in these cells, two different target sequences, EXT1 and EXT2, were amplified. IL-1R1 21 mRNA was detected in spleen and bone marrow cells from wild type and IL-1R1 GR/GR animals 22 but not IL-1R1 r/r animals ( Fig. 5E ), confirming restoration of IL-1R1 in immune cells from IL-23
GR/GR animals. 24
IHC was conducted in IL-1R1
GR/GR animals to identify the cell type that expressed IL-1R1. 25
Results are shown in Fig. 6 . Multiple-channel confocal images were 3d-reconstructed using 1
ImageJ. In Fig. 6A , 3HA tag staining (green) revealed that IL-1R1 mRNA (red, tdTomato) and 2 protein were expressed in the same cells but different locations at the sub-cellular level, 3 consistent with the fact that IL-1R1 mRNA is present in the cytoplasm while IL-1R1 protein is 4 cell membrane anchored. Double labeling of tdTomato with endothelial cell marker Ly6C shows 5 tdTomato expressing cells were exclusively endothelial cells (Fig. 6B) . Nevertheless, endothelial 6 cells comprising capillaries did not express tdTomato. Double labeling of tdTomato with 7 astrocyte cell marker GFAP and microglia cell marker Iba-1 showed no co-localization, 8
indicating that astrocytes or microglia do not have detectable IL-1R1 expression under 9 homeostatic conditions (Fig. 6 C&D) . phenotype. In the IL-1R1 r/r mice, microglia exhibited ramified morphology, indicating they were in 20 an unstimulated resting stage. Results from IL-1 stimulated IL-1R1 r/r mice were not different from 21 those obtained in PBS injected wild type mice (data not shown). Fig. 7M and N shows that in 22 wild type and Tie2Cre-IL-1R1 r/r mice, activated microglia were detected throughout the brain 23 parenchyma whereas in LysMCre-IL-1R1 r/r mice activated microglia were confined only in the 24 hippocampus region. Fig. 7O shows the increased proportional areas of Iba-1 after IL-1 25 stimulation were highest in the wild type animals, intermediate in Tie2Cre-IL-1R1 r/r animals, and 1 lowest in LysMCre-IL-1R1 r/r animals (F(3,8)=5.209; p's≤0.05). To exclude the possibility that the 2 increased proportional area of Iba-1 was not due to reduction of microglia number in the IL-3
1R1
r/r animals, quantification of microglia number in the hippocampus was conducted. No 4 significant difference was found in microglia number among the four genotypes (Fig. 7P) . 5
It has been previously reported that IL-1β gene expression is up-regulated by IL-1β 6 stimulation (Dinarello, 1997). This self-amplification is mediated via IL-1R1 through NF-ƙB and 7 p38 MAPK pathways. We examined IL-1β mRNA expression level in bone marrow cells from 8 
LysMCre-IL-1R1
r/r and IL-1R1 GR/GR mice). The induction of IL-1β mRNA was blocked by NF-ƙB 13 pathway inhibitor BAY11-7082 and p38 MAPK pathway inhibitor SB203580, indicating these 14 signal transduction pathways were also restored in specific cell types. 15
DISCUSSION 16
In the present study we produced an IL-1R1 r/r animal model using knockin strategy. In 17 the IL-1R1 r/r mouse, IL-1-induced CNS effects including brain COX-2 expression, leukocyte 18 trafficking, microglia activation, and IL-1-induced peripheral effects such as the induction of IL-19 1β in bone marrow cells, were all abolished. This is consistent with our design that the IL-1R1 r/r 20 animals should display an IL-1R1 deficient phenotype. In addition, IL-1R1 was restored in the 21 endothelial cells and hematopoietic cells in the Tie2Cre-IL-1R1 r/r and myeloid cells in the 22
LysMCre-IL-1R1
r/r mice as expected. An IL-1R1 GR/GR mouse was also obtained and worked as 23 an IL-1R1 mRNA and protein reporter animal. Therefore, this genetic model fulfilled all of the 24 goals of our design. 25
In fact, the IL-1R1 r/r mouse could serve as a more complete IL-1R1 gene knockout. 1
Previously two IL-1R1 knockout mouse lines were generated (Glaccum et al., 1997; Labow et 2 al., 1997) . However, a recent study showed that in these models a shortened IL-1R1 mRNA can 3 still be expressed due to the existence of an internal promoter in the IL-1R1 gene that is 4 unaffected in the knockouts. This shortened IL-1R1 mRNA can produce IL-1R3 in neural tissues, 5 which is involved in IL-1 induced electrophysiological effects (Qian et al., 2012) . In our IL-1R1 6 restore construct, an interfering DNA segment comprised of three disrupting elements was 7 were not found in other cell types. This observation is consistent with previous results that IL-19 1R1 mRNA is found in endothelial cells by ISHH, but inconsistent with the detection of IL-1R1 20 mRNA in neurons in select regions (Ericsson et al., 1995) . This discrepancy could be explained 21 by the following facts. First, the previous ISHH studies were done on rat tissues, whereas our 22 study was conducted in mice. The species differences may contribute to the variation of IL-1R1 23 significantly enhanced by the use of 3HA epitope tracer. In regard to the identification of IL-1R1 25 expressing cell types, previous IHC studies have generated discrepant results. IL-1R1-ir was 26 found only in endothelial cells in some studies (Konsman et al., 2004; Ravizza and Vezzani, 1 2006; Ching et al., 2007) , only in hippocampal neurons (French et al., 1999) , or in hippocampal 2 neurons and astrocytes (Ravizza and Vezzani, 2006) in other studies. These discrepancies are 3 still difficult to explain. Nonetheless, in our IL-1R1 GR/GR animal, 3HA tagged IL-1R1 protein is 4 expressed in the same cells in which IL-1R1 mRNA is tracked by tdTomato fluorescence. 5 Therefore, the concordant labeling of IL-1R1 mRNA and protein achieved in this model could 6 help avoid potential artifacts in IL-1R1-ir detection. 7
Our results show the IL-1R1 mRNA producing cells from the IL-1R1 GR/GR animal can be 8 enriched and analyzed by FACS analysis. Robust tdTomato fluorescence was detected in a 9 small percentage of isolated brain endothelial cells. Previously, isolated CNS cell types in 10 primary cultures were used to study IL-1R1 mediated signaling (Srinivasan et al., 2004) . In 11 these cultures, it is likely that IL-1R1 expressing cells are mixed with IL-1R1 non-expressing 12 cells, rendering assessment of direct IL-1R1 signaling effects difficult. Because IL-1R1 13 expressing cells from our IL-1R1 GR/GR animal can be enriched and FACS sorted, it is now 14 possible to specifically study IL-1R1 mediated effects from IL-1 expressing cells. LysM Cre mediated restore. It has been shown previously peripheral monocytes may migrate 25 into the brain parenchyma and differentiate into a microglia-like population under certain 26 conditions (Varvel et al., 2012) . Since LysM promoter is not active in the yolk sac derived 1 microglia or other cell types in the brain (Fantin et al., 2010) , it is possible that hippocampus 2 harbors a unique subpopulation of hematopoietically derived microglia during development. 3
These microglia may have their IL-1R1 restored by LysM Cre and become activated after ICV 4 IL-1β injection. This interesting possibility remains to be verified. 5
In summary, the present study demonstrates a powerful genetic mouse model to study 6 cell type specific IL-1R1 mediated responses. This model allows IL-1R1 to be expressed in 7 predetermined cell types and tracked by tdTomato fluorescence and 3HA tagging. With this 8 model IL-1R1 expressing cells can be easily visualized and isolated. In the normal brain 9 endothelial cells in medium size blood vessels were found to be the major producers of IL-1R1 10 and they mediate most central IL-1β induced responses. LysMCre-IL-1R1 r/r and IL-1R1 GR/GR animals were incubated with SB203580 (p38 MAPK inhibitor), 3 BAY11-7082 (NF-ƙB inhibitor) or culture media for 1 hour and challenged with 100 ng/ml IL-1β. 4 IL-1β mRNA was analyzed 24h after IL-1β treatment. Bars represent group means±SEM. * 5 represent significant difference between control and experimental group (p's ≤ 0.05). 6
